Delivery Order SPE2DB24D8002-SPE2DB25FJPMP
- Not listed
- This federal contract award, identified as SPE2DB24D8003/SPE2DB24FJTQJ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,172.28 firm fixed-price delivery order is for the provision of Clomid 50 mg tablets, with a completion date of September 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC), identified as SPE2DB24D8001, which allows...
- This is a delivery order (contract number SPE2DB25FKZKD) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,894.49 firm fixed-price contract is for the delivery of 4567613807 CLOMID 50 MG TABLET UD 30S. The order is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 and a performance period through December 31, 2025. Dakota Drug,...
- This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKYXS, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,572.82 firm fixed-price delivery order is for the provision of 4566692334 - CLOMID 50 MG TABLET UD 30S. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to deliver a broad range of pharmaceutical products, medical supplies, and...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.71 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Premarin 0.625 mg tablets (100-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.22 to Dakota Drug, Inc. on August 25, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place in Anoka, Minnesota. The award utilized no set-aside designation and represents a straightforward pharmaceutical procurement from Dakota Drug, Inc., a self-certified small disadvantaged...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count), with a ceiling value of $5,157.51. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, a delivery order valued at $1,561.25 for 100 tablets of Ambien CR 12.5 mg. This firm fixed-price delivery order, awarded on August 5, 2025, is part of Dakota Drug's larger Indefinite Delivery Contract with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. The award carries no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $3,658.33 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This firm fixed-price delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents an unrestricted award with no set-aside designation. The delivery will be performed in Anoka, Minnesota, where the vendor maintains its...
- The Defense Logistics Agency awarded a $1,072.50 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJPMPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,848.29 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count). This firm fixed price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-set-aside award. The contract will be performed at Dakota Drug's Anoka facility. This delivery order falls under Dakota Drug's larger single-award Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. Dakota Drug serves as a critical supplier within the federal pharmaceutical and medical supply chain, providing an extensive range of medications and healthcare products to support U.S. Armed Forces medical operations. The company has established itself as a key vendor for DLA medical procurement, with a history of delivering diverse pharmaceutical products including pain management, hormonal treatments, and other essential medications to defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/8/25 |